Skip to content
Login

EPLAW Patent Blog: latest European patent law developments

With thanks to our sponsors

https://www.simmons-simmons.com/
https://simontbraun.eu/
https://www.hoyngrokhmonegier.com/
https://powellgilbert.com/
https://www.roschier.com/
https://www.bristows.com/
https://www.arnold-siedsma.com/
https://www.eplaw.org/about/dr-j-alingh-prins-fund/
https://www.pinsentmasons.com/
https://www.freshfields.com/
https://www.danubia.com/
https://www.linklaters.com/
https://www.lenzstaehelin.com/
https://www.gassauer.com/
https://www.bardehle.com/
https://www.coupry.nl/
https://www.stibbe.com/
https://roa.pl/
https://www.arnold-ruess.com/en
https://www.wr.no/
https://www.twobirds.com/
https://www.lagro.com/
https://www.barentskrans.nl/
https://www.brinkhof.com/
https://www.plesner.com/
https://www.vondst.com/
https://www.danubia.com/
30 December 2021
NL – Astrazeneca v. Menzis / Appeal
23 December 2021
EPO – J 8/20 and J 9/20 – Artificial Intelligence – overview
16 December 2021
NL – Bayer Healthcare v. Teva
07 December 2021
EPO – EBA referral G 2/21 – Plausibility and post-published evidence
02 December 2021
NO – Norwegian Parliament establishes patent attorney client-attorney privilege
29 November 2021
EPLAW – Annual Congress and General Assembly 2021
29 November 2021
ES – ERASMUS and INVIVO v. VITRO et al.
24 November 2021
NL – Kiremko v. Tomra
18 November 2021
NL – Nutrition v. Noba / Appeal
16 November 2021
EPO – G 1/21 – Videoconference
08 November 2021
SE – Update Swedish Patent and Market Courts
02 November 2021
NL – Longhi v. Hanwa – execution dispute

EPLAW Patent Blog

Get the latest European patent law developments

BLOG